Avalyn Pharma Inc. Common Stock Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Avalyn Pharma Inc. Common Stock (AVLN) holds an ST Score of 67.2 out of 100 (B), with its strongest factor being Valuation (A-) and its weakest Growth (C). Analysts rate AVLN Buy across 1 ratings with a $60.00 average price target (+0.9% vs the current $31.62).
- Strongest
- ValuationA-
- Weakest
- GrowthC
All factor grades
- ValuationA-
- MomentumA-
- ForecastA-
- ProfitabilityB
- Financial StrengthB
- GrowthC
Contact
AVLN stock: frequently asked questions
What is AVLN's ST Score?
Avalyn Pharma Inc. Common Stock (AVLN) has an ST Score of 67.2 out of 100, an overall grade of B. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is AVLN a buy, sell, or hold?
Wall Street's consensus rating on AVLN is Buy based on 1 analyst ratings. Our own ST Score grades it B (67.2/100). This is data, not investment advice — always do your own research.
What is AVLN's valuation grade?
Avalyn Pharma Inc. Common Stock (AVLN) earns a valuation grade of A-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is AVLN's growth grade?
Avalyn Pharma Inc. Common Stock (AVLN) earns a growth grade of C, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is AVLN's profitability grade?
Avalyn Pharma Inc. Common Stock (AVLN) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is AVLN's financial strength grade?
Avalyn Pharma Inc. Common Stock (AVLN) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for AVLN?
The average analyst price target for Avalyn Pharma Inc. Common Stock (AVLN) is $60.00 from 1 analysts, which is +0.9% versus the recent price of $31.62.